Sanguine Biosciences
Biotechnology Research • 
Woburn, Massachusetts, United States • 101-200 Employees
Company overview
| Headquarters | 400 W Cummings Park, Suite 3050, Woburn, Massachusetts 01801, US |
| Phone number | +18558364759 |
| Website | |
| NAICS | 541714 |
| SIC | 738 |
| Keywords | Observational Studies, Patient Recruitment & Retention, Cell Isolation, Central Laboratory Processing, Longitudinal Biomarker Banking, Mobile Specimen Collection, Registry Building, Leukopaks, Leukapheresis, Longitudinal Sample Collection, Prospective Biospecimen Collection, Ready-To-Ship Biospecimen Samples |
| Founded | 2010 |
| Employees | 101-200 |
| Socials |
Key Contacts at Sanguine Biosciences
Chelsea Caro
Senior Director Of Sales
Eliza Small
Director Of Product Marketing
Brian Vong
Director, Technology Platforms
Hal Flynt
Director Of It
Timothy Jordan
Senior Director, Financial Operations
Dalerae Oppel
Director, Biospecimen Collections
Nicholas Mattera
Director Of Apheresis Operations
Sanguine Biosciences Email Formats
Sanguine Biosciences uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@sanguinebio.com), used 83% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@sanguinebio.com | 83% |
{first initial}{last name} | jdoe@sanguinebio.com | 9.4% |
{last name}{last name} | doedoe@sanguinebio.com | 7.5% |
About Sanguine Biosciences
Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Sanguine actively bridges the gap between patients and researchers through direct-to-patient engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and a suite of biorepository services. Sanguine has supported translational, clinical, and cell & gene therapy research at 35 of the top 40 global pharmaceutical and biotechnology companies, shortening timelines and validating early-stage results to increase confidence and refine biomarkers in human trials. Four years in a row, Sanguine received the prestigious designation of a “Great Places to Work” company. In 2022, Sanguine was designated #2038 on the Inc. 5000 America’s Fastest Growing Private Companies list and achieved recognition on FORTUNE’s 100 Best Small Workplaces and Best Workplaces in Biopharma. Referenced in over 140 publications, Sanguine studies have appeared in high-impact journals, including Science, Nature, NEJM, Nature Medicine, and Science Translational Medicine. Popular media outlets featuring Sanguine include the Fox News Channel, The Washington Post, Inc.,The Boston Globe, Inc., and many others.
Sanguine Biosciences revenue & valuation
| Annual revenue | $8,500,000 |
| Revenue per employee | $77,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $27,200,000 |
| Total funding | $6,000,000 |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Sanguine Biosciences has 59 employees across 13 departments.
Departments
Number of employees
Sanguine Biosciences Tech Stack
Discover the technologies and tools that power Sanguine Biosciences's digital infrastructure, from frameworks to analytics platforms.
Caching
WordPress plugins
CDN
Miscellaneous
Security
Programming languages
Blogs
Video players
SEO
CRM
PaaS
Canada
Switzerland
Germany
BeninFrequently asked questions
4.8
40,000 users
